| Product Code: ETC6749329 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Opioid Receptor Agonist Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Opioid Receptor Agonist Market Revenues & Volume, 2021 & 2031F |
3.3 China Opioid Receptor Agonist Market - Industry Life Cycle |
3.4 China Opioid Receptor Agonist Market - Porter's Five Forces |
3.5 China Opioid Receptor Agonist Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.6 China Opioid Receptor Agonist Market Revenues & Volume Share, By Receptor Binding, 2021 & 2031F |
3.7 China Opioid Receptor Agonist Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.8 China Opioid Receptor Agonist Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 China Opioid Receptor Agonist Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 China Opioid Receptor Agonist Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China Opioid Receptor Agonist Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic pain conditions in China |
4.2.2 Growing awareness about opioid medications for pain management |
4.2.3 Rise in healthcare expenditure and infrastructure development in China |
4.3 Market Restraints |
4.3.1 Stringent regulatory policies related to opioid medications in China |
4.3.2 Concerns about opioid abuse and addiction |
4.3.3 Competition from alternative pain management therapies in the market |
5 China Opioid Receptor Agonist Market Trends |
6 China Opioid Receptor Agonist Market, By Types |
6.1 China Opioid Receptor Agonist Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 China Opioid Receptor Agonist Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 China Opioid Receptor Agonist Market Revenues & Volume, By Fentanyl, 2021- 2031F |
6.1.4 China Opioid Receptor Agonist Market Revenues & Volume, By Codeine, 2021- 2031F |
6.1.5 China Opioid Receptor Agonist Market Revenues & Volume, By Morphine, 2021- 2031F |
6.1.6 China Opioid Receptor Agonist Market Revenues & Volume, By Buprenorphine, 2021- 2031F |
6.1.7 China Opioid Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.2 China Opioid Receptor Agonist Market, By Receptor Binding |
6.2.1 Overview and Analysis |
6.2.2 China Opioid Receptor Agonist Market Revenues & Volume, By Full Agonist, 2021- 2031F |
6.2.3 China Opioid Receptor Agonist Market Revenues & Volume, By Partial Agonist, 2021- 2031F |
6.3 China Opioid Receptor Agonist Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 China Opioid Receptor Agonist Market Revenues & Volume, By Pain management, 2021- 2031F |
6.3.3 China Opioid Receptor Agonist Market Revenues & Volume, By Cough Suppression, 2021- 2031F |
6.3.4 China Opioid Receptor Agonist Market Revenues & Volume, By Diarrhoea suppression, 2021- 2031F |
6.3.5 China Opioid Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.4 China Opioid Receptor Agonist Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 China Opioid Receptor Agonist Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.4.3 China Opioid Receptor Agonist Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.4.4 China Opioid Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.5 China Opioid Receptor Agonist Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 China Opioid Receptor Agonist Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 China Opioid Receptor Agonist Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 China Opioid Receptor Agonist Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.5 China Opioid Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.6 China Opioid Receptor Agonist Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 China Opioid Receptor Agonist Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 China Opioid Receptor Agonist Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.4 China Opioid Receptor Agonist Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 China Opioid Receptor Agonist Market Import-Export Trade Statistics |
7.1 China Opioid Receptor Agonist Market Export to Major Countries |
7.2 China Opioid Receptor Agonist Market Imports from Major Countries |
8 China Opioid Receptor Agonist Market Key Performance Indicators |
8.1 Number of prescriptions for opioid receptor agonists in China |
8.2 Patient satisfaction and pain relief levels with opioid medications |
8.3 Adoption rate of novel opioid receptor agonists in the market |
9 China Opioid Receptor Agonist Market - Opportunity Assessment |
9.1 China Opioid Receptor Agonist Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.2 China Opioid Receptor Agonist Market Opportunity Assessment, By Receptor Binding, 2021 & 2031F |
9.3 China Opioid Receptor Agonist Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.4 China Opioid Receptor Agonist Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 China Opioid Receptor Agonist Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 China Opioid Receptor Agonist Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Opioid Receptor Agonist Market - Competitive Landscape |
10.1 China Opioid Receptor Agonist Market Revenue Share, By Companies, 2024 |
10.2 China Opioid Receptor Agonist Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here